Sodium lactate
Osmoprep, Phosphates (sodium lactate) is a small molecule pharmaceutical. Sodium lactate was first approved as Sodium phosphates in plastic container on 1983-05-10. It is used to treat acidosis in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
|---|---|
| nutritional and metabolic diseases | D009750 |
Trade Name
FDA
EMA
Combinations
Osmoprep, Phosphates (generic drugs available since 2011-12-30, discontinued: Visicol)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Sodium phosphate
+
dibasic
+
anhydrous
+
Sodium phosphate
+
monobasic
+
monohydrate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| OSMOPREP | Salix Pharmaceuticals | N-021892 RX | 2006-03-16 | 1 products, RLD, RS |
Show 1 discontinued
Sodium phosphate
+
dibasic
+
heptahydrate
+
Sodium phosphate
+
monobasic
+
anhydrous
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| SODIUM PHOSPHATES IN PLASTIC CONTAINER | Hospira | N-018892 RX | 1983-05-10 | 1 products, RLD, RS |
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| lactated ringers | New Drug Application | 2022-09-07 |
| osmoprep | New Drug Application | 2019-03-04 |
| potassium phosphates | unapproved drug other | 2022-07-12 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| acidosis | EFO_1000014 | D000138 | E87.2 |
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent | Expires | Flag | FDA Information |
|---|---|---|---|
| Sodium Phosphate, Dibasic, Anhydrous / Sodium Phosphate, Monobasic, Monohydrate, Osmoprep, Salix Pharms | |||
| 7687075 | 2028-06-22 | DS, DP | |
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
936 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| B-cell chronic lymphocytic leukemia | D015451 | C91.1 | 23 | 43 | 6 | 1 | 5 | 69 | |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 12 | 5 | 22 | 1 | 3 | 43 |
| Neoplasms | D009369 | C80 | 12 | 9 | 3 | 1 | 3 | 24 | |
| Human influenza | D007251 | EFO_0007328 | J11.1 | 4 | 7 | 4 | 3 | 1 | 18 |
| Acne vulgaris | D000152 | EFO_0003894 | L70 | 4 | 1 | 5 | 6 | 1 | 16 |
| Hyperphosphatemia | D054559 | HP_0002905 | — | 1 | 4 | 3 | 6 | 13 | |
| Postoperative pain | D010149 | G89.18 | — | 1 | 1 | 4 | 4 | 10 | |
| Malaria | D008288 | EFO_0001068 | B54 | 6 | 1 | — | 2 | — | 8 |
| Covid-19 | D000086382 | U07.1 | 2 | 3 | — | 2 | 2 | 8 | |
| Falciparum malaria | D016778 | EFO_0007444 | B50 | 2 | 3 | 1 | 3 | — | 8 |
Show 60 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Myelodysplastic syndromes | D009190 | D46 | 51 | 97 | 8 | — | 14 | 149 | |
| Leukemia | D007938 | C95 | 37 | 83 | 13 | — | 10 | 122 | |
| Lymphoma | D008223 | C85.9 | 27 | 61 | 4 | — | 15 | 96 | |
| Myeloid leukemia acute | D015470 | C92.0 | 42 | 58 | 5 | — | 5 | 95 | |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | C91.0 | 29 | 43 | 4 | — | 4 | 72 | |
| Non-hodgkin lymphoma | D008228 | C85.9 | 20 | 36 | 1 | — | 5 | 54 | |
| Multiple myeloma | D009101 | C90.0 | 19 | 31 | 2 | — | 6 | 52 | |
| Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | 10 | 33 | 2 | — | 3 | 43 | |
| Hodgkin disease | D006689 | C81 | 13 | 26 | 4 | — | 4 | 41 | |
| Large b-cell lymphoma diffuse | D016403 | C83.3 | 12 | 21 | 2 | — | 3 | 33 |
Show 90 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Plasma cell neoplasms | D054219 | 14 | 28 | — | — | 6 | 44 | ||
| Melanoma | D008545 | 12 | 17 | — | — | — | 27 | ||
| Burkitt lymphoma | D002051 | C83.7 | 6 | 14 | — | — | 3 | 21 | |
| B-cell lymphoma marginal zone | D018442 | C88.4 | 7 | 11 | — | — | 4 | 20 | |
| Primary myelofibrosis | D055728 | D47.4 | 5 | 11 | — | — | 2 | 18 | |
| Large-cell lymphoma anaplastic | D017728 | C84.6 | 5 | 13 | — | — | 3 | 18 | |
| Large-cell lymphoma immunoblastic | D016400 | 5 | 11 | — | — | 3 | 17 | ||
| Lymphomatoid granulomatosis | D008230 | C83.8 | 4 | 11 | — | — | 3 | 16 | |
| Extranodal nk-t-cell lymphoma | D054391 | C86.0 | 4 | 10 | — | — | 3 | 15 | |
| Myeloid leukemia accelerated phase | D015465 | 2 | 11 | — | — | 3 | 15 |
Show 119 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Plasmacytoma | D010954 | C90.3 | 1 | — | — | — | 1 | 2 | |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 1 | — | — | — | 1 | 2 |
| Rickets | D012279 | EFO_0005583 | E55.0 | 1 | — | — | — | 1 | 2 |
| Hepatic insufficiency | D048550 | 2 | — | — | — | — | 2 | ||
| Gram-positive bacterial infections | D016908 | 2 | — | — | — | — | 2 | ||
| Dengue | D003715 | A90 | 2 | — | — | — | — | 2 | |
| Depression | D003863 | F33.9 | 2 | — | — | — | — | 2 | |
| Beta-thalassemia | D017086 | Orphanet_848 | D56.1 | 1 | — | — | — | — | 1 |
| Plantar fasciitis | D036981 | EFO_1001909 | M72.2 | 1 | — | — | — | — | 1 |
| Brain neoplasms | D001932 | EFO_0003833 | C71 | 1 | — | — | — | — | 1 |
Show 25 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hyperlactatemia | D065906 | — | — | — | — | 2 | 2 | ||
| Sars-cov-2 | D000086402 | — | — | — | — | 2 | 2 | ||
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | — | — | — | 2 | 2 |
| Sinus floor augmentation | D059546 | — | — | — | — | 2 | 2 | ||
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | — | — | — | 2 | 2 |
| Papillomaviridae | D027383 | — | — | — | — | 1 | 1 | ||
| Dermatitis | D003872 | HP_0011123 | L30.9 | — | — | — | — | 1 | 1 |
| Sexual behavior | D012725 | — | — | — | — | 1 | 1 | ||
| Hypertrophic cicatrix | D017439 | L91.0 | — | — | — | — | 1 | 1 | |
| Cicatrix | D002921 | HP_0100699 | L90.5 | — | — | — | — | 1 | 1 |
Show 39 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | SODIUM LACTATE |
| INN | compound solution of sodium lactate |
| Description | Sodium lactate is the sodium salt of lactic acid, and has a mild saline taste. It is produced by fermentation of a sugar source, such as corn or beets, and then, by neutralizing the resulting lactic acid to create a compound having the formula NaC3H5O3.
|
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | CC(O)C(=O)[O-].[Na+] |
Identifiers
| PDB | — |
| CAS-ID | 72-17-3 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1357 |
| ChEBI ID | 75228 |
| PubChem CID | 6286 |
| DrugBank | — |
| UNII ID | TU7HW0W0QT (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 92,216 documents
View more details
Safety
Black-box Warning
Black-box warning for: Osmoprep
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
936 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more